List of Tables
    Table 1. Immuno-oncology Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Immuno-oncology Drugs Market Trends
    Table 3. Immuno-oncology Drugs Market Drivers
    Table 4. Immuno-oncology Drugs Market Challenges
    Table 5. Immuno-oncology Drugs Market Restraints
    Table 6. Global Immuno-oncology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Immuno-oncology Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Immuno-oncology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Immuno-oncology Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Immuno-oncology Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Immuno-oncology Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Immuno-oncology Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Immuno-oncology Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Immuno-oncology Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Immuno-oncology Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2021)
    Table 18. Top Players of Immuno-oncology Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Immuno-oncology Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Immuno-oncology Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Immuno-oncology Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Immuno-oncology Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Immuno-oncology Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Immuno-oncology Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Immuno-oncology Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Immuno-oncology Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Immuno-oncology Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Immuno-oncology Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Immuno-oncology Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Immuno-oncology Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Immuno-oncology Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Immuno-oncology Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Immuno-oncology Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Immuno-oncology Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Amgen, Inc Corporation Information
    Table 43. Amgen, Inc Description and Business Overview
    Table 44. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Amgen, Inc Immuno-oncology Drugs Product
    Table 46. Amgen, Inc Recent Development
    Table 47. AstraZeneca, Plc Corporation Information
    Table 48. AstraZeneca, Plc Description and Business Overview
    Table 49. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. AstraZeneca, Plc Product
    Table 51. AstraZeneca, Plc Recent Development
    Table 52. Bristol-Myers Squibb Corporation Information
    Table 53. Bristol-Myers Squibb Description and Business Overview
    Table 54. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol-Myers Squibb Product
    Table 56. Bristol-Myers Squibb Recent Development
    Table 57. Celgene Corporation Corporation Information
    Table 58. Celgene Corporation Description and Business Overview
    Table 59. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Celgene Corporation Product
    Table 61. Celgene Corporation Recent Development
    Table 62. Eli Lilly and Company Corporation Information
    Table 63. Eli Lilly and Company Description and Business Overview
    Table 64. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Eli Lilly and Company Product
    Table 66. Eli Lilly and Company Recent Development
    Table 67. Merck & Co. Corporation Information
    Table 68. Merck & Co. Description and Business Overview
    Table 69. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Merck & Co. Product
    Table 71. Merck & Co. Recent Development
    Table 72. Hoffmann-La Roche AG Corporation Information
    Table 73. Hoffmann-La Roche AG Description and Business Overview
    Table 74. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Hoffmann-La Roche AG Product
    Table 76. Hoffmann-La Roche AG Recent Development
    Table 77. Johnson & Johnson Corporation Information
    Table 78. Johnson & Johnson Description and Business Overview
    Table 79. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Johnson & Johnson Product
    Table 81. Johnson & Johnson Recent Development
    Table 82. Novartis International AG Corporation Information
    Table 83. Novartis International AG Description and Business Overview
    Table 84. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Novartis International AG Product
    Table 86. Novartis International AG Recent Development
    Table 87. AbbVie, Inc. Corporation Information
    Table 88. AbbVie, Inc. Description and Business Overview
    Table 89. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. AbbVie, Inc. Product
    Table 91. AbbVie, Inc. Recent Development
    Table 92. Pfizer Inc. Corporation Information
    Table 93. Pfizer Inc. Description and Business Overview
    Table 94. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Pfizer Inc. Product
    Table 96. Pfizer Inc. Recent Development
    Table 97. Sanofi S.A. Corporation Information
    Table 98. Sanofi S.A. Description and Business Overview
    Table 99. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Sanofi S.A. Product
    Table 101. Sanofi S.A. Recent Development
    Table 102. EMD Serono, Inc. Corporation Information
    Table 103. EMD Serono, Inc. Description and Business Overview
    Table 104. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. EMD Serono, Inc. Product
    Table 106. EMD Serono, Inc. Recent Development
    Table 107. Gilead Sciences Inc. Corporation Information
    Table 108. Gilead Sciences Inc. Description and Business Overview
    Table 109. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Gilead Sciences Inc. Product
    Table 111. Gilead Sciences Inc. Recent Development
    Table 112. Prometheus Therapeutics & Diagnostics Corporation Information
    Table 113. Prometheus Therapeutics & Diagnostics Description and Business Overview
    Table 114. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Prometheus Therapeutics & Diagnostics Product
    Table 116. Prometheus Therapeutics & Diagnostics Recent Development
    Table 117. Aduro BioTech Corporation Information
    Table 118. Aduro BioTech Description and Business Overview
    Table 119. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Aduro BioTech Product
    Table 121. Aduro BioTech Recent Development
    Table 122. Galena Biopharma Corporation Information
    Table 123. Galena Biopharma Description and Business Overview
    Table 124. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Galena Biopharma Product
    Table 126. Galena Biopharma Recent Development
    Table 127. Bavarian Nordic Corporation Information
    Table 128. Bavarian Nordic Description and Business Overview
    Table 129. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Bavarian Nordic Product
    Table 131. Bavarian Nordic Recent Development
    Table 132. Celldex Therapeutics Corporation Information
    Table 133. Celldex Therapeutics Description and Business Overview
    Table 134. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Celldex Therapeutics Product
    Table 136. Celldex Therapeutics Recent Development
    Table 137. ImmunoCellular Therapeutics Corporation Information
    Table 138. ImmunoCellular Therapeutics Description and Business Overview
    Table 139. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. ImmunoCellular Therapeutics Product
    Table 141. ImmunoCellular Therapeutics Recent Development
    Table 142. Incyte Corporation Information
    Table 143. Incyte Description and Business Overview
    Table 144. Incyte Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Incyte Product
    Table 146. Incyte Recent Development
    Table 147. Dendreon Corporation Corporation Information
    Table 148. Dendreon Corporation Description and Business Overview
    Table 149. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Dendreon Corporation Product
    Table 151. Dendreon Corporation Recent Development
    Table 152. Agilent Technologies Inc. Corporation Information
    Table 153. Agilent Technologies Inc. Description and Business Overview
    Table 154. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Agilent Technologies Inc. Product
    Table 156. Agilent Technologies Inc. Recent Development
    Table 157. Agenus Inc. Corporation Information
    Table 158. Agenus Inc. Description and Business Overview
    Table 159. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Agenus Inc. Product
    Table 161. Agenus Inc. Recent Development
    Table 162. Enzo Biochem, Inc. Corporation Information
    Table 163. Enzo Biochem, Inc. Description and Business Overview
    Table 164. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Enzo Biochem, Inc. Product
    Table 166. Enzo Biochem, Inc. Recent Development
    Table 167. Lonza Group Corporation Information
    Table 168. Lonza Group Description and Business Overview
    Table 169. Lonza Group Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 170. Lonza Group Product
    Table 171. Lonza Group Recent Development
    Table 172. Bio-Rad Laboratories, Inc. Corporation Information
    Table 173. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 174. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 175. Bio-Rad Laboratories, Inc. Product
    Table 176. Bio-Rad Laboratories, Inc. Recent Development
    Table 177. Avantor, Inc. Corporation Information
    Table 178. Avantor, Inc. Description and Business Overview
    Table 179. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 180. Avantor, Inc. Product
    Table 181. Avantor, Inc. Recent Development
    Table 182. Spring Bank Pharmaceuticals, Inc. Corporation Information
    Table 183. Spring Bank Pharmaceuticals, Inc. Description and Business Overview
    Table 184. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 185. Spring Bank Pharmaceuticals, Inc. Product
    Table 186. Spring Bank Pharmaceuticals, Inc. Recent Development
    Table 187. Ferring Pharmaceuticals Corporation Information
    Table 188. Ferring Pharmaceuticals Description and Business Overview
    Table 189. Ferring Pharmaceuticals Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 190. Ferring Pharmaceuticals Product
    Table 191. Ferring Pharmaceuticals Recent Development
    Table 192. Key Raw Materials Lists
    Table 193. Raw Materials Key Suppliers Lists
    Table 194. Immuno-oncology Drugs Customers List
    Table 195. Immuno-oncology Drugs Distributors List
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immuno-oncology Drugs Product Picture
    Figure 2. Global Immuno-oncology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Immuno-oncology Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Immuno-oncology Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Immuno-oncology Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Immuno-oncology Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Immuno-oncology Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Immuno-oncology Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Immuno-oncology Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Immuno-oncology Drugs Report Years Considered
    Figure 11. Product Picture of Immune Checkpoint Inhibitors
    Figure 12. Product Picture of Immune System Modulators
    Figure 13. Product Picture of Cancer Vaccines
    Figure 14. Product Picture of Oncolytic Virus
    Figure 15. Product Picture of Others
    Figure 16. Global Immuno-oncology Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Immuno-oncology Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Immuno-oncology Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Immuno-oncology Drugs Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Immuno-oncology Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Immuno-oncology Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Immuno-oncology Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Immuno-oncology Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Immuno-oncology Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Immuno-oncology Drugs Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Immuno-oncology Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Immuno-oncology Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Hospitals
    Figure 29. Product Picture of Clinics
    Figure 30. Product Picture of Ambulatory Surgical Centers
    Figure 31. Global Immuno-oncology Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Immuno-oncology Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Immuno-oncology Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Immuno-oncology Drugs Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Immuno-oncology Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Immuno-oncology Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Immuno-oncology Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Immuno-oncology Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Immuno-oncology Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Immuno-oncology Drugs Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Immuno-oncology Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Immuno-oncology Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Immuno-oncology Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Immuno-oncology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Immuno-oncology Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Immuno-oncology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Immuno-oncology Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Immuno-oncology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Immuno-oncology Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Immuno-oncology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Immuno-oncology Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Immuno-oncology Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Immuno-oncology Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Immuno-oncology Drugs Value Chain
    Figure 77. Immuno-oncology Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed